Rb Capital Management, LLC Bristol Myers Squibb CO Transaction History

Rb Capital Management, LLC

  • $407 Million
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $56,472 - $64,028
-1,177 Reduced 20.4%
4,592 $249,000
Q4 2023

Feb 05, 2024
SELL
$48.48 - $57.85 $106,607 - $127,212
-2,199 Reduced 27.6%
5,769 $296,000
Q3 2023

Nov 15, 2023
BUY
$57.89 - $64.73 $1,042 - $1,165
18 Added 0.23%
7,968 $462,000
Q2 2023

Dec 11, 2023
SELL
$63.71 - $70.74 $1,146 - $1,273
-18 Reduced 0.23%
7,950 $508,000
Q2 2023

Aug 07, 2023
SELL
$63.71 - $70.74 $2,166 - $2,405
-34 Reduced 0.43%
7,950 $508,000
Q1 2023

May 09, 2023
BUY
$65.71 - $74.53 $47,705 - $54,108
726 Added 10.0%
7,984 $553,000
Q4 2022

Jan 10, 2023
BUY
$68.48 - $81.09 $15,476 - $18,326
226 Added 3.21%
7,258 $522,000
Q3 2022

Oct 21, 2022
BUY
$0.13 - $76.84 $19 - $11,372
148 Added 2.15%
7,032 $500,000
Q2 2022

Jul 14, 2022
SELL
$72.62 - $79.98 $21,858 - $24,073
-301 Reduced 4.19%
6,884 $530,000
Q1 2022

Apr 11, 2022
BUY
$61.48 - $73.72 $5,164 - $6,192
84 Added 1.18%
7,185 $525,000
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $41,938 - $48,890
-782 Reduced 9.92%
7,101 $443,000
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $16,567 - $19,406
-280 Reduced 3.43%
7,883 $466,000
Q2 2021

Aug 06, 2021
SELL
$61.91 - $67.42 $8,357 - $9,101
-135 Reduced 1.63%
8,163 $545,000
Q1 2021

May 11, 2021
SELL
$59.34 - $66.74 $3,857 - $4,338
-65 Reduced 0.78%
8,298 $524,000
Q4 2020

Feb 04, 2021
BUY
$57.74 - $65.43 $110,225 - $124,905
1,909 Added 29.58%
8,363 $519,000
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $33,941 - $37,611
-591 Reduced 8.39%
6,454 $382,000
Q2 2020

Jul 31, 2020
BUY
$54.82 - $64.09 $2,576 - $3,012
47 Added 0.67%
7,045 $414,000
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $2,088 - $3,034
45 Added 0.65%
6,998 $386,000
Q4 2019

Feb 11, 2020
BUY
$49.21 - $64.19 $114,757 - $149,691
2,332 Added 50.47%
6,953 $437,000
Q3 2019

Oct 10, 2019
SELL
$42.77 - $50.71 $42,000 - $49,797
-982 Reduced 17.53%
4,621 $235,000
Q2 2019

Aug 07, 2019
BUY
$44.62 - $49.34 $2,186 - $2,417
49 Added 0.88%
5,603 $254,000
Q1 2019

May 08, 2019
BUY
$45.12 - $53.8 $225 - $269
5 Added 0.09%
5,554 $265,000
Q4 2018

Jan 15, 2019
SELL
$48.76 - $63.23 $19,455 - $25,228
-399 Reduced 6.71%
5,549 $288,000
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $17,660 - $19,920
-320 Reduced 5.11%
5,948 $369,000
Q2 2018

Jul 30, 2018
BUY
$50.53 - $62.98 $3,486 - $4,345
69 Added 1.11%
6,268 $347,000
Q1 2018

Apr 19, 2018
SELL
$59.92 - $68.98 $15,878 - $18,279
-265 Reduced 4.1%
6,199 $392,000
Q4 2017

Feb 05, 2018
BUY
$59.94 - $65.35 $2,157 - $2,352
36 Added 0.56%
6,464 $396,000
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $355,018 - $409,720
6,428
6,428 $0

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rb Capital Management, LLC Portfolio

Follow Rb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email